Integrating computational pathology and proteomics to address tumor heterogeneity

Area of Science:

• Oncology
• Proteomics
• Computational Pathology

Background:

• Despite molecular advances, precision medicine struggles with cancer treatment efficacy.
• Proteogenomic discordances and spatial tumor heterogeneity limit therapeutic success.
• Understanding tumor biology variation is crucial for effective cancer therapies.

Purpose of the Study:

• To address limitations in precision medicine caused by tumor heterogeneity.
• To explore the integration of proteomics and computational imaging for cancer research.
• To improve regional sampling strategies in cancer studies.

Main Methods:

• Discusses mass spectrometry-based global proteomics for molecular profiling.
• Highlights computational imaging for spatial analysis of tumor biology.
• Proposes integrating these techniques for targeted regional sampling.

Main Results:

• Proteogenomic discordances contribute to challenges in precision medicine.
• Spatial heterogeneity within tumors complicates molecular profiling.
• Integrated approaches offer a path to overcome biologic variation.

Conclusions:

• Integrating proteomics and computational imaging can enhance understanding of tumor heterogeneity.
• This integrated approach can guide regional sampling for more effective cancer research.
• Addressing proteogenomic discordances is key to advancing precision oncology.